{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T16:51:57Z","timestamp":1774111917797,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00277-015-2354-7","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T14:23:50Z","timestamp":1427898230000},"page":"1119-1125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Osteopontin: a potential biomarker of Gaucher disease"],"prefix":"10.1007","volume":"94","author":[{"given":"Filippo","family":"Vairo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Sperb-Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristiane","family":"Michellin-Tirelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Netto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eurico Camargo","family":"Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,1]]},"reference":[{"issue":"Suppl 1","key":"2354_CR1","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1007\/s00431-003-1348-y","volume":"162","author":"PJ Meikle","year":"2003","unstructured":"Meikle PJ, Hopwood JJ (2003) Lysosomal storage disorders: emerging therapeutic options require early diagnosis. Eur J Pediatr 162(Suppl 1):S34\u2013S37","journal-title":"Eur J Pediatr"},{"issue":"1","key":"2354_CR2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajh.21888","volume":"86","author":"PK Mistry","year":"2011","unstructured":"Mistry PK, Cappellini MD, Lukina E, Ozsan H, Mach Pascual S, Rosenbaum H et al (2011) A reappraisal of Gaucher disease-diagnosis and disease management algorithms. Am J Hematol 86(1):110\u2013115","journal-title":"Am J Hematol"},{"issue":"451","key":"2354_CR3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/08035320600619039","volume":"95","author":"E Beutler","year":"2006","unstructured":"Beutler E (2006) Gaucher disease: multiple lessons from a single gene disorder. Acta Paediatr Suppl 95(451):103\u2013109","journal-title":"Acta Paediatr Suppl"},{"issue":"2","key":"2354_CR4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","volume":"129","author":"M Jmoudiak","year":"2005","unstructured":"Jmoudiak M, Futerman AH (2005) Gaucher disease: pathological mechanisms and modern management. Br J Haematol 129(2):178\u2013188","journal-title":"Br J Haematol"},{"issue":"23\u201324","key":"2354_CR5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s10354-010-0864-4","volume":"160","author":"DA Hughes","year":"2010","unstructured":"Hughes DA, Pastores GM (2010) The pathophysiology of GD - current understanding and rationale for existing and emerging therapeutic approaches. Wien Med Wochenschr 160(23\u201324):594\u2013599","journal-title":"Wien Med Wochenschr"},{"issue":"3","key":"2354_CR6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","volume":"122","author":"LA Boven","year":"2004","unstructured":"Boven LA, van Meurs M, Boot RG, Mehta A, Boon L, Aerts JM et al (2004) Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol 122(3):359\u2013369","journal-title":"Am J Clin Pathol"},{"issue":"16","key":"2354_CR7","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","volume":"14","author":"I Ron","year":"2005","unstructured":"Ron I, Horowitz M (2005) ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Hum Mol Genet 14(16):2387\u20132398","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2354_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2004.09.004","volume":"18","author":"D Pelled","year":"2005","unstructured":"Pelled D, Trajkovic-Bodennec S, Lloyd-Evans E, Sidransky E, Schiffmann R, Futerman AH (2005) Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Neurobiol Dis 18(1):83\u201388","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2354_CR9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcp.21023","volume":"212","author":"M Deganuto","year":"2007","unstructured":"Deganuto M, Pittis MG, Pines A, Dominissini S, Kelley MR, Garcia R et al (2007) Altered intracellular redox status in Gaucher disease fibroblasts and impairment of adaptive response against oxidative stress. J Cell Physiol 212(1):223\u2013235","journal-title":"J Cell Physiol"},{"issue":"5","key":"2354_CR10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/auto.6.5.12047","volume":"6","author":"Y Sun","year":"2010","unstructured":"Sun Y, Grabowski GA (2010) Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease. Autophagy 6(5):648\u2013649","journal-title":"Autophagy"},{"issue":"Suppl 2","key":"2354_CR11","first-page":"106","volume":"24","author":"TM Cox","year":"2001","unstructured":"Cox TM (2001) Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. J Inherit Metab Dis 24(Suppl 2):106\u2013121, discussion 87-8","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"2354_CR12","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","volume":"96","author":"MT Moran","year":"2000","unstructured":"Moran MT, Schofield JP, Hayman AR, Shi GP, Young E, Cox TM (2000) Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K. Blood 96(5):1969\u20131978","journal-title":"Blood"},{"issue":"2","key":"2354_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","volume":"23","author":"CE Hollak","year":"1997","unstructured":"Hollak CE, Evers L, Aerts JM, van Oers MH (1997) Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells Mol Dis 23(2):201\u2013212","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"2354_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bcmd.2010.10.010","volume":"46","author":"EV Pavlova","year":"2011","unstructured":"Pavlova EV, Deegan PB, Tindall J, McFarlane I, Mehta A, Hughes D et al (2011) Potential biomarkers of osteonecrosis in Gaucher disease. Blood Cells Mol Dis 46(1):27\u201333","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"2354_CR15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0950-3536(97)80034-0","volume":"10","author":"JM Aerts","year":"1997","unstructured":"Aerts JM, Hollak CE (1997) Plasma and metabolic abnormalities in Gaucher\u2019s disease. Bailliere\u2019s Clin Haematol 10(4):691\u2013709","journal-title":"Bailliere\u2019s Clin Haematol"},{"issue":"3","key":"2354_CR16","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","volume":"93","author":"CE Hollak","year":"1994","unstructured":"Hollak CE, van Weely S, van Oers MH, Aerts JM (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Investig 93(3):1288\u20131292","journal-title":"J Clin Investig"},{"issue":"1","key":"2354_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","volume":"103","author":"RG Boot","year":"2004","unstructured":"Boot RG, Verhoek M, de Fost M, Hollak CE, Maas M, Bleijlevens B et al (2004) Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 103(1):33\u201339","journal-title":"Blood"},{"issue":"16","key":"2354_CR18","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","volume":"118","author":"N Dekker","year":"2011","unstructured":"Dekker N, van Dussen L, Hollak CE, Overkleeft H, Scheij S, Ghauharali K et al (2011) Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. Blood 118(16):e118\u2013e127","journal-title":"Blood"},{"issue":"11","key":"2354_CR19","doi-asserted-by":"crossref","first-page":"e79732","DOI":"10.1371\/journal.pone.0079732","volume":"8","author":"A Rolfs","year":"2013","unstructured":"Rolfs A, Giese AK, Grittner U, Mascher D, Elstein D, Zimran A et al (2013) Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients. PLoS One 8(11):e79732","journal-title":"PLoS One"},{"issue":"1\u20132","key":"2354_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0167-4838(89)90092-7","volume":"996","author":"DR Senger","year":"1989","unstructured":"Senger DR, Perruzzi CA, Papadopoulos A, Tenen DG (1989) Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta 996(1\u20132):43\u201348","journal-title":"Biochim Biophys Acta"},{"issue":"23","key":"2354_CR21","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1073\/pnas.83.23.8819","volume":"83","author":"A Oldberg","year":"1986","unstructured":"Oldberg A, Franzen A, Heinegard D (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A 83(23):8819\u20138823","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2354_CR22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1359-6101(96)00030-5","volume":"7","author":"GF Weber","year":"1996","unstructured":"Weber GF, Cantor H (1996) The immunology of Eta-1\/osteopontin. Cytokine Growth Factor Rev 7(3):241\u2013248","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"2354_CR23","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/sj.bjc.6601839","volume":"90","author":"SR Rittling","year":"2004","unstructured":"Rittling SR, Chambers AF (2004) Role of osteopontin in tumour progression. Br J Cancer 90(10):1877\u20131881","journal-title":"Br J Cancer"},{"issue":"1","key":"2354_CR24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfm246","volume":"103","author":"SK Ramaiah","year":"2008","unstructured":"Ramaiah SK, Rittling S (2008) Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci : Off J Soc Toxicol 103(1):4\u201313","journal-title":"Toxicol Sci : Off J Soc Toxicol"},{"issue":"2","key":"2354_CR25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/(SICI)1097-4652(199805)175:2<229::AID-JCP13>3.0.CO;2-3","volume":"175","author":"K Atkins","year":"1998","unstructured":"Atkins K, Berry JE, Zhang WZ, Harris JF, Chambers AF, Simpson RU et al (1998) Coordinate expression of OPN and associated receptors during monocyte\/macrophage differentiation of HL-60 cells. J Cell Physiol 175(2):229\u2013237","journal-title":"J Cell Physiol"},{"issue":"8","key":"2354_CR26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1089\/jir.2006.26.562","volume":"26","author":"S Konno","year":"2006","unstructured":"Konno S, Eckman JA, Plunkett B, Li X, Berman JS, Schroeder J et al (2006) Interleukin-10 and Th2 cytokines differentially regulate osteopontin expression in human monocytes and dendritic cells. J Interf Cytokine Res : Off J Int Soc Interferon and Cytokine Res 26(8):562\u2013567","journal-title":"J Interf Cytokine Res : Off J Int Soc Interferon and Cytokine Res"},{"issue":"5","key":"2354_CR27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/107999003321829971","volume":"23","author":"X Li","year":"2003","unstructured":"Li X, O\u2019Regan AW, Berman JS (2003) IFN-gamma induction of osteopontin expression in human monocytoid cells. J Interf Cytokine Res : Off J Int Soc Interferon and Cytokine Res 23(5):259\u2013265","journal-title":"J Interf Cytokine Res : Off J Int Soc Interferon and Cytokine Res"},{"issue":"4","key":"2354_CR28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1365-2567.1996.d01-691.x","volume":"88","author":"EE Rollo","year":"1996","unstructured":"Rollo EE, Denhardt DT (1996) Differential effects of osteopontin on the cytotoxic activity of macrophages from young and old mice. Immunology 88(4):642\u2013647","journal-title":"Immunology"},{"issue":"4","key":"2354_CR29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1189\/jlb.68.4.495","volume":"68","author":"AW O\u2019Regan","year":"2000","unstructured":"O\u2019Regan AW, Hayden JM, Berman JS (2000) Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J Leukoc Biol 68(4):495\u2013502","journal-title":"J Leukoc Biol"},{"issue":"7","key":"2354_CR30","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/art.24625","volume":"60","author":"W Zheng","year":"2009","unstructured":"Zheng W, Li R, Pan H, He D, Xu R, Guo TB et al (2009) Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis. Arthritis Rheum 60(7):1957\u20131965","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2354_CR31","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.yexcr.2006.12.026","volume":"313","author":"T Nystrom","year":"2007","unstructured":"Nystrom T, Duner P, Hultgardh-Nilsson A (2007) A constitutive endogenous osteopontin production is important for macrophage function and differentiation. Exp Cell Res 313(6):1149\u20131160","journal-title":"Exp Cell Res"},{"issue":"2","key":"2354_CR32","first-page":"353","volume":"152","author":"CM Giachelli","year":"1998","unstructured":"Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M (1998) Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152(2):353\u2013358","journal-title":"Am J Pathol"},{"issue":"1","key":"2354_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2004.01.001","volume":"227","author":"B Bourassa","year":"2004","unstructured":"Bourassa B, Monaghan S, Rittling SR (2004) Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice. Cell Immunol 227(1):1\u201311","journal-title":"Cell Immunol"},{"issue":"4","key":"2354_CR34","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bone.2008.06.010","volume":"43","author":"CE Pedraza","year":"2008","unstructured":"Pedraza CE, Nikolcheva LG, Kaartinen MT, Barralet JE, McKee MD (2008) Osteopontin functions as an opsonin and facilitates phagocytosis by macrophages of hydroxyapatite-coated microspheres: implications for bone wound healing. Bone 43(4):708\u2013716","journal-title":"Bone"},{"issue":"3","key":"2354_CR35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2006.04.013","volume":"89","author":"AC Vedder","year":"2006","unstructured":"Vedder AC, Cox-Brinkman J, Hollak CE, Linthorst GE, Groener JE, Helmond MT et al (2006) Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy. Mol Genet Metab 89(3):239\u2013244","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2354_CR36","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.clinthera.2014.03.017","volume":"36","author":"AD Dornelles","year":"2014","unstructured":"Dornelles AD, de Oliveira Netto CB, Vairo F, de Mari JF, Tirelli KM, Schwartz IV (2014) Breastfeeding in Gaucher disease: is enzyme replacement therapy safe? Clin Ther 36(6):990\u2013991","journal-title":"Clin Ther"},{"issue":"2","key":"2354_CR37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-007-0296-4","volume":"115","author":"JA Castaneda","year":"2008","unstructured":"Castaneda JA, Lim MJ, Cooper JD, Pearce DA (2008) Immune system irregularities in lysosomal storage disorders. Acta Neuropathol 115(2):159\u2013174","journal-title":"Acta Neuropathol"},{"key":"2354_CR38","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1017\/S1462399411001839","volume":"13","author":"SR Rittling","year":"2011","unstructured":"Rittling SR (2011) Osteopontin in macrophage function. Expert Rev Mol Med 13:e15","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"2354_CR39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/humrep\/15.3.713","volume":"15","author":"R Raghupathy","year":"2000","unstructured":"Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R (2000) Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 15(3):713\u2013718","journal-title":"Hum Reprod"},{"issue":"12","key":"2354_CR40","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/rheumatology\/ken385","volume":"47","author":"ST Choi","year":"2008","unstructured":"Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB et al (2008) Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis. Rheumatology (Oxford) 47(12):1775\u20131779","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2354_CR41","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1442-200X.2007.02502.x","volume":"49","author":"M Yoshino","year":"2007","unstructured":"Yoshino M, Watanabe Y, Tokunaga Y, Harada E, Fujii C, Numata S et al (2007) Roles of specific cytokines in bone remodeling and hematopoiesis in Gaucher disease. Pediatr Int : Off J Jpn Pediatr Soc 49(6):959\u2013965","journal-title":"Pediatr Int : Off J Jpn Pediatr Soc"},{"issue":"5\u20136","key":"2354_CR42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cytogfr.2008.08.001","volume":"19","author":"KX Wang","year":"2008","unstructured":"Wang KX, Denhardt DT (2008) Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 19(5\u20136):333\u2013345","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"2354_CR43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/1566524013363339","volume":"1","author":"KA Furger","year":"2001","unstructured":"Furger KA, Menon RK, Tuck AB, Bramwell VH, Chambers AF (2001) The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med 1(5):621\u2013632","journal-title":"Curr Mol Med"},{"issue":"6","key":"2354_CR44","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1055-9965.EPI-06-1008","volume":"16","author":"LR Rodrigues","year":"2007","unstructured":"Rodrigues LR, Teixeira JA, Schmitt FL, Paulsson M, Lindmark-Mansson H (2007) The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomark Prev: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16(6):1087\u20131097","journal-title":"Cancer Epidemiol Biomark Prev: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"4","key":"2354_CR45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2141.2005.05886.x","volume":"132","author":"J Caers","year":"2006","unstructured":"Caers J, Gunthert U, De Raeve H, Van Valckenborgh E, Menu E, Van Riet I et al (2006) The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model. Br J Haematol 132(4):469\u2013477","journal-title":"Br J Haematol"},{"issue":"3","key":"2354_CR46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nbd.2006.10.020","volume":"25","author":"W Maetzler","year":"2007","unstructured":"Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC et al (2007) Osteopontin is elevated in Parkinson\u2019s disease and its absence leads to reduced neurodegeneration in the MPTP model. Neurobiol Dis 25(3):473\u2013482","journal-title":"Neurobiol Dis"},{"issue":"5","key":"2354_CR47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00702-009-0209-x","volume":"116","author":"W Maetzler","year":"2009","unstructured":"Maetzler W, Michelis J, Tomiuk J, Melms A, Becker C, Gasser T et al (2009) A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease. J Neural Transm 116(5):599\u2013605","journal-title":"J Neural Transm"},{"key":"2354_CR48","first-page":"615745","volume":"2013","author":"Y Sun","year":"2013","unstructured":"Sun Y, Yin XS, Guo H, Han RK, He RD, Chi LJ (2013) Elevated osteopontin levels in mild cognitive impairment and Alzheimer\u2019s disease. Mediat Inflamm 2013:615745","journal-title":"Mediat Inflamm"},{"issue":"Pt 5","key":"2354_CR49","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","volume":"137","author":"M Siebert","year":"2014","unstructured":"Siebert M, Sidransky E, Westbroek W (2014) Glucocerebrosidase is shaking up the synucleinopathies. Brain 137(Pt 5):1304\u20131322","journal-title":"Brain"},{"issue":"7","key":"2354_CR50","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/mds.23595","volume":"26","author":"A Ribner","year":"2011","unstructured":"Ribner A, Altarescu G, Zimran A, Elstein D (2011) Osteopontin polymorphic susceptibility factor for Parkinson\u2019s disease among patients with Gaucher disease. Mov Disord 26(7):1341\u20131343","journal-title":"Mov Disord"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2354-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2354-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T03:53:31Z","timestamp":1717818811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2354-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2354"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2354-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,1]]}}}